Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Fagron SA Logo
Fagron SA Growth Score
89
CB Rank
40805
Heat Score
62
Fagron is a pharmaceutical company specializing in chemicals, equipment, and supplies solutions.
Founded
obfuscation
PublicPost-IPO Debt Rotterdam, Zuid-Holland, The Netherlands1001-5000 fagron.com/
Biotechnology
Health Care
Medical
Pharmaceutical
Overview

Fagron SA
Total Funding
obfuscation
Growth Score
89
Heat Score
62

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score89
-6 pts
in past quarter
Heat Score 62
3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Fagron SA

CB Rank
40805
Fagron is a pharmaceutical company specializing in chemicals, equipment, and supplies solutions.
Founded
obfuscation
PublicPost-IPO Debt Rotterdam, Zuid-Holland, The Netherlands1001-5000 fagron.com/
Biotechnology
Health Care
Medical
Pharmaceutical

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Fagron Group BV
Operating Status Active
Stock Symbol  EBR:FAGR
Company Type For Profit
Founders  Ger van Jeveren
About the Company
Fagron is the global pharmaceutical compounding company, bringing customized pharmaceutical care to hospitals, pharmacies, clinics and patients in 34 countries worldwide.
Phone Number +31 88 33 11 288
Contact Email info@fagron.us
Predictions & Insights

Growth Insight

See this Growth Insight
Fagron SA is
Lorem
 to be growing
Top Contributing Factors
Operations Expansion

Products & Services

Fagron Formulary
A global initiative providing pharmacists and prescribers with a broad range of customized pharmaceutical formulas linked to specific medical indications.
FagronLab™
A global product line of pharmaceutical compounding equipment designed for use in compounding pharmacies and laboratories.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
1
obfuscation
PGIMPost-IPO Debt
obfuscation
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
1
obfuscation
PGIMPost-IPO Debt
obfuscation
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
1
obfuscation
PGIMPost-IPO Debt
obfuscation
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
1
obfuscation
PGIMPost-IPO Debt
obfuscation
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
1
obfuscation
PGIMPost-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
1
obfuscation
PGIMPost-IPO Debt
obfuscation
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
1
obfuscation
PGIMPost-IPO Debt
obfuscation
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
1
obfuscation
PGIMPost-IPO Debt
obfuscation
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
1
obfuscation
PGIMPost-IPO Debt
obfuscation
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
1
obfuscation
PGIMPost-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
PGIM Logo
PGIM
Yes
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
—
PGIM Logo
PGIM
Yes
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
—
PGIM Logo
PGIM
Yes
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
—
PGIM Logo
PGIM
Yes
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
—
PGIM Logo
PGIM
Yes
Post-IPO Debt - Fagron SA Logo
Post-IPO Debt - Fagron SA
—

Investments

Number of Acquisitions 26

Investment Breakdown

Number of Acquisitions 26
Market Intelligence
People
View Profiles & Contacts
Headcount 1001-5000 Employee Profiles 4 Board Members and Advisors 5 Contacts 201

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

24,988
-48.41%
 in past month

IT Spend

$34.8MThis year, Fagron SA is projected to spend $34.8M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Row-Based Cooling Logo
Row-Based Cooling
100
Predictive Apps Logo
Predictive Apps
99
Payroll Services Logo
Payroll Services
96

Actively Used Products

34Fagron SA uses 34 technology products and services including HTML5, Amazon EC2, and  Google Tag Manager, according to G2 Stack.

Active Website Tech Count

10Fagron SA is actively using 10 technologies for its website, according to BuiltWith. These include IPv6, IIS 10, and  ASP.NET.

Total IP

25The intellectual property of Fagron SA includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Fagron SA has registered 22 trademarks with the most popular class being 'Chemical substances', according to IPqwery.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 7
Which industries do these Sub-Organization operate in?
University Compound Pharmacy Logo
University Compound PharmacySubsidiary
Tamda Logo
TamdaSubsidiary
SB Trade Logo
SB TradeSubsidiary
Fagron Sterile Services Logo
Fagron Sterile ServicesSubsidiary
Central de Drogas Logo
Central de DrogasSubsidiary
ApodanNordic PharmaPackaging Logo
ApodanNordic PharmaPackagingSubsidiary
AnazaoHealth Corporation Logo
AnazaoHealth CorporationSubsidiary
Frequently Asked Questions

Where is Fagron SA's headquarters? Fagron SA is located in Rotterdam, Zuid-Holland, The Netherlands.Who invested in Fagron SA? Fagron SA has 3 investors including PGIM and  Waterland Private Equity.When was the last funding round for Fagron SA? Fagron SA closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Fagron SA's competitors? Alternatives and possible competitors to Fagron SA may include HERMES PHARMA, Epic Medical, and  Chemoteka.How much funding has Fagron SA raised to date? Fagron SA has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|